Teva Of Israel Doubles U.S. Lobbying Expenditures In First Quarter
This article was originally published in PharmAsia News
Executive Summary
Israel's Teva Pharmaceutical Industries nearly doubled its lobbying efforts in the United States during this year's first quarter, spending $1.44 million